Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1312, 2010-01, pp. : 4-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Hydrochlorothiazide halts the progression of nephrocalcinosis
Inpharma, Vol. 1, Iss. 1301, 2001-01 ,pp. :
Access to resources
Recommend
Pharmacogenomic considerations for immunosuppressive therapy
Pharmacogenomics, Vol. 4, Iss. 3, 2003-05 ,pp. :
Immunosuppressive Therapy for Myelodysplastic Syndromes
Current Pharmaceutical Design, Vol. 18, Iss. 22, 2012-07 ,pp. :
Denosumab HALTs bone loss during AI therapy for breast cancer
Inpharma, Vol. 1, Iss. 1620, 2008-01 ,pp. :
Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 13, Iss. 2, 2013-06 ,pp. :